Advances in TAVR: A Review of Current Evidence and Clinical Implications

Atiq Ur Rehman; Faiz Ullah; Rahim Dil Khan; Muhammad Idrees Khan; Ajmal Khan

doi:10.70749/ijbr.v3i4.1240

Authors

Atiq Ur Rehman Peshawar Institute of Cardiology, Peshawar, Pakistan
Faiz Ullah Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Rahim Dil Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Idrees Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Ajmal Khan Rehman College of Allied Health Science, Rehman Medical Institute, Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i4.1240

Keywords:

TAVR, Aortic Stenosis, Valve Replacement, Procedural Outcomes, Pakistan

Abstract

Introduction: Transcatheter aortic valve replacement (TAVR) has taken place alongside surgical aortic valve replacement (SAVR) as an effective therapy for aortic stenosis – especially for patients with high and intermediate surgical risk. Subsequent developments have expanded these indications to include low-risk and other technically challenging subgroups. Objective: To evaluate the clinical outcomes and procedural success of TAVR in a tertiary care hospital in Pakistan. Materials and Method: This prospective observational study was conducted at Hayatabad Medical Complex Peshawar, Pakistan from January, 2024 to June, 2024. The inclusion criteria were symptomatic severe aortic stenosis patients, and they underwent TAVR with either balloon-expandable or self-expanding valves. Results: In 108 patients, the procedural success rate was 97.2%. Mean aortic valve area increased post-procedure, and there were low short-term adverse events mortality 1.9%, stroke 2.8%, and pacemaker implantation 10.2%. Conclusion: Real-world studies have shown that TAVR is a safe and effective approach for aortic stenosis in patients and supports procedural and clinical success.

Downloads

Download data is not yet available.

References

Avvedimento, M. and Tang, G.H., 2021. Transcatheter aortic valve replacement (TAVR): recent updates. Progress in cardiovascular diseases, 69, pp.73-83.

https://doi.org/10.1016/j.pcad.2021.11.003

Vincent, F., Ternacle, J., Denimal, T., Shen, M., Redfors, B., Delhaye, C., Simonato, M., Debry, N., Verdier, B., Shahim, B. and Pamart, T., 2021. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation, 143(10), pp.1043-1061.

https://doi.org/10.1161/circulationaha.120.048048

Zaidi, S.H., Minhas, A.M.K., Sagheer, S., ManeshGangwani, K., Dani, S.S., Goel, S.S., Alam, M., Sheikh, A.B., Hirji, S. and Wasty, N., 2022. Clinical outcomes of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with durable left ventricular assist device (LVAD). Current Problems in Cardiology, 47(10), p.101313.

https://doi.org/10.1016/j.cpcardiol.2022.101313

Mack, M.J., Leon, M.B., Thourani, V.H., Pibarot, P., Hahn, R.T., Genereux, P., Kodali, S.K., Kapadia, S.R., Cohen, D.J., Pocock, S.J. and Lu, M., 2023. Transcatheter aortic-valve replacement in low-risk patients at five years. New England Journal of Medicine, 389(21), pp.1949-1960.

https://doi.org/10.1056/nejmoa2307447

Sá, M.P.B., Van den Eynde, J., Simonato, M., Cavalcanti, L.R.P., Doulamis, I.P., Weixler, V., Kampaktsis, P.N., Gallo, M., Laforgia, P.L., Zhigalov, K. and Ruhparwar, A., 2021. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: an updated meta-analysis. Cardiovascular Interventions, 14(2), pp.211-220.

https://doi.org/10.1016/j.jcin.2020.10.020

Van Mieghem, N.M., Elmariah, S., Spitzer, E., Pibarot, P., Nazif, T.M., Bax, J.J., Hahn, R.T., Popma, A., Ben-Yehuda, O., Kallel, F. and Redfors, B., 2025. Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD. Journal of the American College of Cardiology, 85(9), pp.878-890.

https://doi.org/10.1016/j.jacc.2024.10.070

Généreux, P., Schwartz, A., Oldemeyer, B., Cohen, D.J., Redfors, B., Prince, H., Zhao, Y., Lindman, B.R., Pibarot, P. and Leon, M.B., 2024. Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial. American Heart Journal, 268, pp.94-103.

https://doi.org/10.1016/j.ahj.2023.11.019

Gallo, M., Fovino, L.N., Blitzer, D., Doulamis, I.P., Guariento, A., Salvador, L., Tagliari, A.P. and Ferrari, E., 2022. Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review. European Journal of Cardio-Thoracic Surgery, 61(5), pp.967-976.

https://doi.org/10.1093/ejcts/ezab443

Leon, M.B., Mack, M.J., Hahn, R.T., Thourani, V.H., Makkar, R., Kodali, S.K., Alu, M.C., Madhavan, M.V., Chau, K.H., Russo, M. and Kapadia, S.R., 2021. Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk. Journal of the American College of Cardiology, 77(9), pp.1149-1161.

https://doi.org/10.1016/j.jacc.2020.12.052

Srinivasan, A., Wong, F. and Wang, B., 2024. Transcatheter aortic valve replacement: Past, present, and future. Clinical Cardiology, 47(1), p.e24209.

https://doi.org/10.1002/clc.24209

Costa, G., Saia, F., Pilgrim, T., Abdel-Wahab, M., Garot, P., Valvo, R., Gandolfo, C., Branca, L., Latib, A., Santos, I.A. and Mylotte, D., 2022. Transcatheter aortic valve replacement with the latest-iteration self-expanding or balloon-expandable valves: the multicenter OPERA-TAVI registry. Cardiovascular Interventions, 15(23), pp.2398-2407.

https://doi.org/10.1016/j.jcin.2022.08.057

Miyamoto, J., Ohno, Y., Kamioka, N., Ikari, Y., Otsuka, T., Tada, N., Naganuma, T., Yamawaki, M., Yamanaka, F., Shirai, S. and Mizutani, K., 2022. Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement. Journal of the American College of Cardiology, 80(17), pp.1601-1613.

https://doi.org/10.1016/j.jacc.2022.08.757

Prosperi-Porta, G., Nguyen, V., Willner, N., Dreyfus, J., Eltchaninoff, H., Burwash, I.G., Michel, M., Durand, E., Gilard, M., Dindorf, C. and Iung, B., 2023. Association of age and sex with use of transcatheter aortic valve replacement in France. Journal of the American College of Cardiology, 82(20), pp.1889-1902.

https://doi.org/10.1016/j.jacc.2023.08.044

Ludwig, S., Schofer, N., Abdel-Wahab, M., Urena, M., Jean, G., Renker, M., Hamm, C.W., Thiele, H., Iung, B., Ooms, J.F. and Wiessman, M., 2023. Transcatheter aortic valve replacement in patients with reduced ejection fraction and nonsevere aortic stenosis. Circulation: Cardiovascular Interventions, 16(5), p.e012768.

https://doi.org/10.1161/circinterventions.122.012768

Del Val, D., Panagides, V., Mestres, C.A., Miró, J.M. and Rodés-Cabau, J., 2023. Infective endocarditis after transcatheter aortic valve replacement: JACC state-of-the-art review. Journal of the American College of Cardiology, 81(4), pp.394-412.

https://doi.org/10.1016/j.jacc.2022.11.028